Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 9—September 2004

Perspective

Potential Public Health Impact of New Tuberculosis Vaccines

Elad Ziv*, Charles L. Daley*†, and Sally Blower‡Comments to Author 
Author affiliations: *University of California—San Francisco, San Francisco, California, USA; †San Francisco General Hospital, San Francisco, California, USA; ‡David Geffen School of Medicine at UCLA, Los Angeles California, USA

Main Article

Figure 4

Unadjusted predicted data are plotted; red points represent postexposure vaccines, black points represent preexposure vaccines. A) Cumulative percentage of tuberculosis (TB) cases prevented. B) Cumulative percentage of TB cases prevented. C) Cumulative percentage of TB cases prevented. Cases prevented after 20 years of vaccination are shown as a function of vaccination coverage rates, duration of vaccine-induced immunity, or vaccine efficacy.

Figure 4. Unadjusted predicted data are plotted; red points represent postexposure vaccines, black points represent preexposure vaccines. A) Cumulative percentage of tuberculosis (TB) cases prevented. B) Cumulative percentage of TB cases prevented. C) Cumulative percentage of TB cases prevented. Cases prevented after 20 years of vaccination are shown as a function of vaccination coverage rates, duration of vaccine-induced immunity, or vaccine efficacy.

Main Article

TOP